Geriatric Oncology Follow-up in the Alpine Valley

NCT03349229 | Unknown

• 2 other identifiers: 38RC16.0582017-A00434-49
• Study Type: observational
• Target: 4,000
• Locations: 1 country
• Sites: 1

Brief Summary

As the french population is ageing, the question of medical care in elderly cancer patients is fundamental. A third of all cancer patients are 70 years or older. This population has specific challenges: autonomy maintenance, treatments efficacy with limited side effects. As a result of a call to projects, the Geriatric Oncology unit of the French Alps (UCOGAlp) has been selected by the National Institute of Cancer (INCa). It includes 15 centres in the Alpine area. This unit has been evaluated patients since 2011, giving them a full geriatric evaluation and trying to establish adapted cares. In order to evaluate the impact of those evaluation on patients' health, the investigators have developped a geriatric follow-up after 1 month (D30) and 4 months (D120). The investigators want to develop a common data base to these centres, in order to evaluate the care practices that were developped, and demonstrate the benefit for the patient on the dependence level and the overall survival.

Conditions

Oncology; Aging

Keywords

care practices; geriatry; oncology

Outcome Measures

Primary Outcomes (1)

• Evaluation of care practices in geriatric oncology

  Change in number of geriatric follow ups at D30 and D120

  4 months

Secondary Outcomes (2)

• Dependence of the patients

  4 months

• Overall survival according to care decisions

  2 years

Eligibility Criteria

• Age: 70 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The patients that are recruited for this study are people over 70 years old, recently diagnosed with cancer. They are the patients in the hospitals that usually treat cancer patients. They have to be evaluated by a geriatrician, either after a clinical evaluation, or after they passed an Oncodage G8 test. This test has been validated in France in 2014, then in the international community (Soubeyran et al.). Ths protocole is for all cancer patients, and any cancer localisation. Even if the treatment is only palliative care, the patients can be in the study. The patients have to live in the following countys: Isère, Haute Savoie, Savoie. The participants need to have a geriatric follow up in one of the centers that participates to the SONGAlp study, between January 2013 and December 2017.

You may qualify if:

• Patients over 70 years old
• Patients diagnosed with cancer (any histologic types)
• Patients amongst the UCOGAlp followup, which includes all patients in the 8 centers that participate

You may not qualify if:

• Patients under 70 years old
• Patients with no cancer
• Patients that are not amongst the UCOGAlp followup

Sponsors & Collaborators

• University Hospital, Grenoble: lead

Study Sites (1)

CHU Grenoble Alpes

La Tronche, 38700, France

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

• Gaëtan GAVAZZI, PHD

  CHU Grenoble Alpes

  PRINCIPAL INVESTIGATOR

• Pascale GUILLEM, PHD

  CHU Grenoble Alpes

  STUDY DIRECTOR

Central Study Contacts

Gaëtan GAVAZZI, PHD

CONTACT

+33476767575; ggavazzi@chu-grenoble.fr

Isabelle MARTY

CONTACT

+33476767575

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 48 Months
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 13, 2017
• First Posted: November 21, 2017
• Study Start: April 1, 2017
• Primary Completion: April 1, 2021
• Study Completion: April 1, 2021
• Last Updated: November 13, 2020

Record last verified: 2020-11

Locations

FR (1)